CASP3 and hepatocellular carcinoma: Its mechanism might be partially related to apoptosis induction in hepatocellular carcinoma cells by downregulating prostaglandin E receptor EP2 levels, increasing the Bax/Bcl-2 ratio and thus upregulating the activation of caspase-3 (Hu et al., 2013).